What Is PGS in IVF? Embryo Screening Explained

PGS is a test done during IVF that checks each embryo for a missing or extra chromosome before one is chosen for transfer. Clinics now call it PGT-A, but it is the same test.1Chelsea Fertility NYC. What Is the Difference Between PGS and PGT-A? It can’t make an embryo healthier; it only helps pick among the embryos you already have. So whether it helps depends mostly on your age and history, and for many younger patients it doesn’t raise the overall chance of a baby.2Elsevier / Fertility and Sterility. The use of preimplantation genetic testing for aneuploidy: a committee opinion

What PGS (PGT-A) Actually Tests

PGT-A stands for preimplantation genetic testing for aneuploidy, and PGS was its older name.1Chelsea Fertility NYC. What Is the Difference Between PGS and PGT-A? Aneuploid means an embryo has the wrong number of chromosomes, more or fewer than the usual 46. Euploid means it has the normal number.

Most clinics now take the sample on day 5, when the embryo is a ball of about 80 to 100 cells.3PubMed Central. Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects The embryologist removes five or six cells from the outer layer that later forms the placenta.3PubMed Central. Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects The cells that become the baby are left untouched.

Early versions could check only five or six chromosomes, so problems in the rest went unseen.4PubMed Central. In vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrangements comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing Today’s tests, mostly sequencing, check all 24 chromosome types at once.4PubMed Central. In vitro fertilization outcomes after preimplantation genetic testing for chromosomal structural rearrangements comparing fluorescence in-situ hybridization, microarray comparative genomic hybridization, and next-generation sequencing

The few cells go to a genetic lab, often a separate company from your clinic, while the embryo stays frozen at the clinic. The lab copies the tiny amount of DNA so it can be read, then compares the amount of each chromosome against a normal reference.

The report usually labels each embryo euploid, aneuploid or mosaic (a mix of the two). Many reports also list the embryo’s sex, since the test sees the sex chromosomes. Results usually take one to two weeks, so the embryos are frozen and one is transferred in a later cycle. It’s worth asking whether the clinic will discuss mosaic results with you before discarding anything.

PGT-A does not test for single-gene conditions like cystic fibrosis; that is a different test, PGT-M. A normal result doesn’t guarantee a pregnancy or a healthy baby, and prenatal screening during pregnancy is still recommended.

Why Age Changes the Odds of Abnormal Embryos

Chromosome errors in embryos mostly start when the egg divides its chromosomes as it matures.5PubMed. Aneuploidy in mammalian oocytes and the impact of maternal ageing In human eggs, chromosomes often separate incorrectly even in younger women.5PubMed. Aneuploidy in mammalian oocytes and the impact of maternal ageing These errors rise from the mid-thirties, which is a main cause of age-related infertility.5PubMed. Aneuploidy in mammalian oocytes and the impact of maternal ageing The reason is that the protein “glue” holding chromosome pairs together weakens as eggs age, letting pairs come apart too early.6PubMed Central. Meiotic Origins of Maternal Age-Related Aneuploidy So the older the egg, the larger the share of embryos with the wrong number of chromosomes.

Most embryos with the wrong count fail to implant or end in early miscarriage, which is why they explain many failed transfers in older patients. What matters is the age of the egg, not the age of the person carrying the pregnancy, so donor eggs from young women behave like young eggs. Sperm contribute far fewer chromosome errors than eggs, so the egg’s age matters most.

Even in someone in their twenties, a meaningful share of embryos have the wrong chromosome number, because egg division is error-prone in everyone. Age shifts the share but never takes it to zero, so an abnormal embryo doesn’t mean you did something wrong.

Does PGS Increase Your Chance of a Baby

PGT-A has not been shown to help as a routine test for everyone doing IVF.2Elsevier / Fertility and Sterility. The use of preimplantation genetic testing for aneuploidy: a committee opinion Large multicenter trials found pregnancy results from frozen transfers similar with or without it.2Elsevier / Fertility and Sterility. The use of preimplantation genetic testing for aneuploidy: a committee opinion In more than 133,000 US first IVF cycles, it was linked to a lower overall chance of a baby from one egg collection at every age up to 40.7PubMed Central. PGT-A is associated with reduced cumulative live birth rate in first reported IVF stimulation cycles age ≤ 40: an analysis of 133,494 autologous cycles reported to SART CORS That drop was largest under age 35.7PubMed Central. PGT-A is associated with reduced cumulative live birth rate in first reported IVF stimulation cycles age ≤ 40: an analysis of 133,494 autologous cycles reported to SART CORS One reason is that a test can wrongly label a normal embryo as abnormal, and that embryo is then never used.

“Overall chance of a baby” here means the share of people who have a baby after using all the embryos from one egg collection, including later transfers of any that remain. Untested patients may need more transfers, and some fail, but the leftover embryos still get their turn. For younger people, most embryos are already normal, so there is little to gain from sorting and mostly a risk of setting aside good ones.

What PGT-A does improve is the route. It can cut time in treatment by up to four months, and people who use it have fewer failed transfers and fewer miscarriages.8PubMed. Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage So it changes how quickly you get there more than whether you get there.

Clinics often quote success per transfer, which looks higher with PGT-A because weaker embryos are removed first. The number that matters is your chance of a baby from all embryos of one egg collection, so ask the clinic for both figures for someone your age.

Some cycles produce no embryo labelled normal, ending the cycle with no transfer. Without testing, some of those embryos might have been transferred, and some could have worked. For people with one or two day 5 embryos, the test may remove options rather than add them.

Who Is Most Likely to Benefit

In the large US data, the drop in overall chance of a baby was not seen over age 40.7PubMed Central. PGT-A is associated with reduced cumulative live birth rate in first reported IVF stimulation cycles age ≤ 40: an analysis of 133,494 autologous cycles reported to SART CORS On cost, testing works out about even once roughly 57% or fewer embryos are normal, which is typical from about age 37.9Fertility and Sterility. Cost-Effectiveness of Preimplantation Genetic Testing for Aneuploidy in Patients at Low Risk of Aneuploidy Around that age a large share of embryos are abnormal, so sorting has more to do. Age is a guide, not a cutoff: someone at 36 with few embryos and someone at 39 with many may be in very different positions.

The missing drop after 40 means testing was not linked to harm there, not that it was proven to raise the chance of a baby. At this age there may be very few embryos to test, so some people end up with nothing to transfer.

For people with unexplained repeated miscarriages, testing cut the chance of losing a pregnancy by more than half.10PubMed. Preimplantation genetic testing for aneuploidy in unexplained recurrent pregnancy loss: a systematic review and meta-analysis In US frozen transfers for this group, the chance of a baby per transfer was 48% with testing versus 34% without.11Human Reproduction. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study But in one group the per-transfer gain held at 35 and over but not under 35, and overall odds per egg collection were similar.12PubMed. Effects of NGS-based PGT-a for idiopathic recurrent pregnancy loss and implantation failure: a retrospective cohort study So for younger people with repeated loss, the main gain is reaching a baby faster with fewer losses. For unexplained repeated implantation failure, testing made no difference to results at any age.12PubMed. Effects of NGS-based PGT-a for idiopathic recurrent pregnancy loss and implantation failure: a retrospective cohort study

Some questions to bring to your doctor:

  • How many day 5 embryos do people with my age and egg count usually get?
  • What share of them is expected to be normal?
  • Would testing change which embryo I transfer, or just the order?
  • Does my history of losses or failed transfers make testing more useful?

What a Mosaic Result Means

A mosaic embryo has some cells with a normal chromosome count and some with an abnormal one. Mosaic embryos led to a baby in about 47% of transfers versus 59% for normal ones.13PubMed Central. Rates of live birth after mosaic embryo transfer compared with euploid embryo transfer Once they implant, though, miscarriage rates are similar to normal embryos.14PubMed Central. Live birth and other reproductive outcomes of mosaic and euploid embryos: a systematic review and meta-analysis So the main risk is that the embryo doesn’t implant, not a later loss.

Some mosaic results are better than others. Mosaics affecting only part of one chromosome do better than those affecting whole chromosomes.14PubMed Central. Live birth and other reproductive outcomes of mosaic and euploid embryos: a systematic review and meta-analysis Mosaic embryos from eggs of women 34 or younger also do better.15PubMed. One hundred mosaic embryos transferred prospectively in a single clinic: exploring when and why they result in healthy pregnancies And repeat biopsies of the same mosaic embryo often give different results,15PubMed. One hundred mosaic embryos transferred prospectively in a single clinic: exploring when and why they result in healthy pregnancies so a mosaic label is a probability, not a verdict.

The few cells sampled may not represent the whole embryo, so a mosaic call can reflect a small edge of the embryo or a real mix throughout. Some mosaic embryos may even correct themselves, though how often is still debated. Labs also differ in the level at which they call an embryo mosaic, so the same embryo might be labelled differently elsewhere.

A mosaic embryo is usually considered when no normal embryo is available. A genetic counselor can explain the specific chromosome involved, and prenatal testing in pregnancy is usually advised after a mosaic transfer. Before signing anything, ask whether the clinic stores or discards mosaic embryos.

Is the Biopsy Safe for the Embryo and Baby

Day 5 biopsied embryos implanted at about the same rate as untested ones, 51% versus 54%.16PubMed. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial Older day 3 biopsy cut the share leading to a baby from 50% to 30%.16PubMed. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial That’s why it’s worth asking your clinic to confirm it biopsies at day 5.

In more than 1,700 babies born after day 5 biopsy, birth weight and preterm birth rates matched other IVF babies.17PubMed. Neonatal outcomes of live births after blastocyst biopsy in preimplantation genetic testing cycles: a follow-up of 1,721 children Growth up to age 2 was similar after biopsy.18PubMed Central. Cleavage-stage or blastocyst-stage embryo biopsy has no impact on growth and health in children up to 2 years of age But no long-term studies yet follow children after day 5 biopsy.19PubMed Central. Obstetric, neonatal, and child health outcomes following embryo biopsy for preimplantation genetic testing

The biopsy itself is done by a trained embryologist who uses a fine tool, often a laser, to make a small opening in the outer shell and gently remove a few cells. By day 5 the embryo has plenty of cells, so a few removed cells are a small fraction of it. The embryologist’s skill matters, and clinics that do many biopsies tend to have more reliable technique.

Cost and Whether It Is Worth It

For people at low risk of abnormal embryos, PGT-A added about $3,800 per cycle for about a 3.6% higher chance of a baby.9Fertility and Sterility. Cost-Effectiveness of Preimplantation Genetic Testing for Aneuploidy in Patients at Low Risk of Aneuploidy That works out to over $100,000 per extra baby.9Fertility and Sterility. Cost-Effectiveness of Preimplantation Genetic Testing for Aneuploidy in Patients at Low Risk of Aneuploidy In fresh donor-egg cycles it added about $6,000 and was not good value.20PubMed Central. Cost-effectiveness of preimplantation genetic testing for aneuploidy for fresh donor oocyte cycles It may save costs elsewhere by cutting failed transfers and months of treatment.8PubMed. Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage For someone with a high chance of abnormal embryos, the same fee buys more benefit, which is why value improves with age.

The fee covers the biopsy and the lab analysis, and it often does not include freezing, storage or the later transfer. If you would have frozen embryos anyway, the freezing cost is smaller, but a fresh transfer you might otherwise have done is no longer an option.

To work out your own costs, ask whether the price is per embryo or per cycle, and include the frozen transfer cost, since tested embryos are always frozen. Check whether insurance covers testing for your age or miscarriage history. And weigh the emotional cost of failed transfers and losses alongside the money.

Lab Differences and Non-Invasive Tests

Different genetic labs reported different rates of normal embryos and births from similar donor eggs.21PubMed. Reproductive genetics laboratory may impact euploid blastocyst and live birth rates: a comparison of 4 national laboratories’ PGT-A results from vitrified donor oocytes Each lab sets its own thresholds for calling an embryo normal, abnormal or mosaic, so identical embryos can be graded differently. Your result reflects both the embryo and the lab’s rules, so ask which lab your clinic uses and its track record.

A newer test reads DNA the embryo sheds into its culture fluid, with no cells removed. One study found it wrongly labelled about half of normal embryos as abnormal.22PubMed Central. Extended blastocyst culture improves DNA yield in non-invasive preimplantation genetic testing for aneuploidy but diagnostic specificity remains limited Those embryos went on to give a baby in 88% of transfers.22PubMed Central. Extended blastocyst culture improves DNA yield in non-invasive preimplantation genetic testing for aneuploidy but diagnostic specificity remains limited Other labs report better accuracy with stricter methods,23PubMed Central. Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsy but for now it’s best treated as experimental.

You may also be offered AI scoring of embryo images, sometimes combined with PGT-A. In one study, better-scored normal embryos were more likely to lead to pregnancy. These tools rank embryos; they don’t change which embryos can work.

Sex Selection and Emotional Weight

Because the test counts the sex chromosomes, the lab can usually tell the sex of each embryo, whether or not you asked. Clinics set their own rules on choosing sex for non-medical reasons.24PubMed. Use of reproductive technology for sex selection for nonmedical reasons: an Ethics Committee opinion Laws differ by country, so check the rules if you’re treated abroad. They also differ in whether they share the information, so ask before testing how yours handles it. Some people prefer not to know until birth, and many clinics can withhold it on request.

Most people who used embryo testing support it for disease but oppose trait selection.25PubMed. Ethical and moral perspectives of individuals who considered/used preimplantation (embryo) genetic testing Deciding whether to test is often very stressful and brings uncertainty,26PubMed Central. Patients’ preimplantation genetic testing decision-making experience: an opinion on related psychological frameworks so ask for genetic counseling before you decide.